Patent: 10,105,415
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,105,415
Title: | Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease |
Abstract: | The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as Crohn\'s disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen. |
Inventor(s): | Heslet; Lars (Gentofte, DK), Uttenthal; Lars Otto (Salamanca, ES) |
Assignee: | Reponex Pharmaceuticals A/S (Horsholm, DK) |
Application Number: | 15/328,426 |
Patent Claims: | see list of patent claims |
Details for Patent 10,105,415
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | TRASYLOL | aprotinin | Injection | 020304 | 12/29/1993 | See Plans and Pricing | 2034-07-24 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | 03/05/1991 | See Plans and Pricing | 2034-07-24 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | Injection | 103362 | 03/05/1991 | See Plans and Pricing | 2034-07-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |